MiMedx Group, Inc.
MDXG
$6.96
-$0.21-2.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 352.38M | 348.88M | 342.81M | 340.46M | 334.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 352.38M | 348.88M | 342.81M | 340.46M | 334.51M |
| Cost of Revenue | 63.64M | 60.07M | 57.01M | 56.47M | 55.20M |
| Gross Profit | 288.73M | 288.81M | 285.80M | 283.99M | 279.31M |
| SG&A Expenses | 220.92M | 216.39M | 210.18M | 208.55M | 215.82M |
| Depreciation & Amortization | 674.00K | 764.00K | 763.00K | 761.00K | 762.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 298.07M | 289.57M | 279.15M | 277.14M | 283.81M |
| Operating Income | 54.31M | 59.31M | 63.65M | 63.32M | 50.71M |
| Income Before Tax | 54.50M | 57.29M | 59.96M | 57.97M | 43.93M |
| Income Tax Expenses | 14.54M | 15.30M | -25.89M | -28.84M | -34.51M |
| Earnings from Continuing Operations | 39.96 | 42.00 | 85.85 | 86.81 | 78.44 |
| Earnings from Discontinued Operations | 221.00K | 421.00K | 2.61M | 2.09M | -5.97M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 40.18M | 42.42M | 88.46M | 88.90M | 72.47M |
| EBIT | 54.31M | 59.31M | 63.65M | 63.32M | 50.71M |
| EBITDA | 62.81M | 65.35M | 67.51M | 66.86M | 53.98M |
| EPS Basic | 0.27 | 0.29 | 0.63 | 0.63 | 0.51 |
| Normalized Basic EPS | 0.23 | 0.25 | 0.28 | 0.28 | 0.23 |
| EPS Diluted | 0.27 | 0.28 | 0.59 | 0.60 | 0.49 |
| Normalized Diluted EPS | 0.23 | 0.25 | 0.26 | 0.25 | 0.19 |
| Average Basic Shares Outstanding | 588.57M | 587.70M | 560.06M | 529.40M | 497.94M |
| Average Diluted Shares Outstanding | 596.19M | 596.54M | 595.38M | 596.78M | 594.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.42% | -- | -- | -- | -- |